期刊文献+

应用单核苷酸多态性微阵列技术诊断Rubinstein-Taybi综合征1例报告 被引量:10

Application of single nucleotide polymorphism microarray technology in diagnosis of Rubinstein-Taybi syndrome:one case report
下载PDF
导出
摘要 目的探讨Rubinstein-Taybi综合征的诊断策略。方法对1例临床表现符合Rubinstein-Taybi综合征诊断的患儿应用SNP-array技术进行全基因组拷贝数的变异分析。结果患儿男,2个月,发现16号染色体短臂13.3存在1.8 Mb的缺失变异,位于chr16:2903942-4748851,该区段包含致病基因CREBBP。结论 SNP-array等染色体微阵列分析(CMA)技术可应用于Rubenstein-Taybi综合征的分子诊断。 Objective To explore the diagnosis strategy of Rubinstein-Taybi syndrome. Methods SNP-array technology was used to analyze the variation of whole genome copy number in one patient whose clinical features were in accord with the diagnosis of Rubinstein-Taybi syndrome. Results Two-months-old male patient had been detected to have 1. 8 Mb deletion mutation in 16 p 13. 3 region(chr 16 : 2903942- 4748851), in which the pathogenic CREBBP gene was located. Conclusions Chromosomal microarray analysis(CMA) technology, such as SNP-array, can be used to make a molecular diagnosis of Rubinstein-Taybi syndrome.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2016年第9期686-688,共3页 Journal of Clinical Pediatrics
关键词 单核苷酸多态性微阵列 Rubenstein-Taybi综合征 分子诊断 single nucleotide polymorphism array Rubinstein-Taybi syndrome molecular diagnosis
  • 相关文献

参考文献13

  • 1Milani D, Manzoni FM, Pezzani L, et al. Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management [J]. Ital J Pediatr, 2015, 41: 4.
  • 2何健峰,田杰,白永虹,余更生,刘晓燕,李谧,蒲晓芳,罗雪,林琴.Rubinstein-Taybi综合征1例[J].中国循证儿科杂志,2006,1(1):72-72. 被引量:3
  • 3StefM, Simon D, Mardirossian B, et al. Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients [J]. Eur J Hum Genet, 2007, 15(8): 843-847.
  • 4Petrij F, Dorsman JC, Dauwerse HG, et al. Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2; 16)(q36.3,p13.3) [J]. Am J Med Genet, 2000, 92(1): 47-52.
  • 5Tajir M, Fergelot P, Lancelot G, et al. Germline mosaicism in Rubinstein-Taybi syndrome [J]. Gene, 2013, 518(2): 476-478.
  • 6Petrij F, Dauwerse HG, Blough R.I, et al. Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations [J]. J Med Genet, 2000, 37(3): 168-176.
  • 7Taine L, Goizet C, Wen ZQ, et al. Submicroscopic deletion of chromosome 16p13.3 in patients with Rubinstein-Taybi syndrome [J]. Am J Med Genet, 1998, 78(3): 267-270.
  • 8Coupry I, Monnet L, Attia AA, et al. Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR [J]. Hum Mutat, 2004, 23(3): 278-284.
  • 9Vissers LE, van Ravenswaaij CM, Admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome [J]. Nat Genet, 2004, 36(9): 955-957.
  • 10Stankiewicz P, Sen P, Bhatt SS, et al. Genomic and genic deletions of the FOXgene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations [J]. Am J Hum Genet, 2009, 84(6): 780-791.

共引文献2

同被引文献32

引证文献10

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部